20th Jan 2009 09:26
News Release
Guernsey, 20 January 2009
Princess partnerships expand their investment in healthcare company
Princess portfolio partnerships Bain Capital X and TPG III made a follow-on investment in Quintiles Transnational Corp., a provider of professional services to the healthcare market, to finance its acquisition of Targeted Molecular Diagnostics (TMD). The addition of TMD, a developer of biomarker technologies for oncology research, strengthens Quintiles' service offerings in oncology, an increasingly important growth area of drug development. TMD is especially attractive as it provides Quintiles with advanced in-house capabilities, adding significant new proficiencies much sought after by Quintiles' clients.
Sandra Pajarola, Partner at Princess' investment advisor Partners Group, comments: "We are pleased to observe the further expansion of Quintiles, resulting in the opportunity of capitalizing on TMD's valuable resources. This shows that there are sectors and companies with healthy development irrespective of the challenging economic outlook. Portfolio companies active in relatively recession-resilient industry segments such as healthcare hence become increasingly important amid a recessionary market environment as they contribute to a portfolio's overall stability."
About Princess
Princess is an investment holding company founded in 1999 and domiciled in Guernsey that invests in private equity and private debt investments. The Company is advised in its investment activities by Partners Group AG, a global alternative asset management firm listed on the SWX Swiss Exchange (ticker symbol: PGHN) with over CHF 24 billion assets under management in private equity, private debt, private real estate, private infrastructure, absolute return strategies and listed alternatives. Princess aims to provide shareholders with long-term capital growth and an attractive dividend yield. Princess is traded on the Frankfurt Stock Exchange (ticker symbol: PEY1) and on the London Stock Exchange (ticker symbol: PEY). Further information: www.princess-privateequity.net
Contacts
Princess Private Equity Holding Limited:
www.princess-privateequity.net
Registered Number: 35241
Media enquiries:
Partners Group AG
Dr. Cyrill Wipfli
Head Communications
Tel.: +41 41 768 85 71
www.partnersgroup.net
This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Princess Private Equity Holding Limited. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about, and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein is not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.
This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document.
Approved by Partners Group (UK) Ltd., authorised and regulated by the Financial Services Authority in the United Kingdom.
Related Shares:
Partners Grp E